Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valtoco effect on RNS activity in epilepsy
NCT05273398Phase 4Completed
- Sponsor
- University of Cincinnati
- Start
- Mar 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of diazepam nasal spray in focal epilepsy, sponsored by University of Cincinnati. Started Mar 2022; status: completed.
02
Drugs
diazepam nasal spray
03
Conditions
focal epilepsy
Beyond the preview
Go deeper on NCT05273398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05273398.